Menora Mivtachim Holdings Ltd.

13F Holdings History for UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)

Symbol: URGN on Nasdaq
Investment type: Equity / Ordinary Shares, par value NIS 0.01 per share
Latest Disclosed Ownership: 2.3M shares
Security Ownership: 4.99%

Shares, Excluding Options vs Price

Value, Excluding Options

Menora Mivtachim Holdings Ltd ownership in UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN)

2025-03-17 - Menora Mivtachim Holdings Ltd has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.3M shares of UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN). This represents 4.99% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Menora Mivtachim Holdings Ltd	4.99%		$22.2M	2.3M			$9.66	13G/A	3/11/2025	17 Mar 2025 13:23:02

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.12%		$23M	1.15M			$19.95	Q3 2025
6/30/2025	0.09%	-0.09%	$15.8M	1.15M	-1,150,500	-50%	$13.70	Q2 2025
3/31/2025	0.17%		$25.5M	2.3M			$11.06	Q1 2025
12/31/2024	0.15%		$24.5M	2.3M			$10.65	Q4 2024
9/30/2024	0.18%		$29.2M	2.3M			$12.70	Q3 2024
6/30/2024	0.26%		$38.6M	2.3M			$16.78	Q2 2024
3/31/2024	0.26%		$34.5M	2.3M			$15.00^*	Q1 2024
12/31/2023	0.29%		$34.5M	2.3M			$15.00	Q4 2023
9/30/2023	0.29%	-0.03%	$32.3M	2.3M	-226,789	-8.96%	$14.01	Q3 2023
6/30/2023	0.24%	-0.04%	$26.2M	2.53M	-389,183	-13.3%	$10.35	Q2 2023
3/31/2023	0.28%		$27M	2.92M			$9.24	Q1 2023
12/31/2022	0.44%		$25.9M	2.92M			$8.87	Q4 2022
9/30/2022	0.46%	0%	$24.3M	2.92M	-30,486	-1.03%	$8.32	Q3 2022
6/30/2022	0.44%	0%	$24.2M	2.95M	-3,000	-0.1%	$8.19	Q2 2022
3/31/2022	0.37%		$25.7M	2.95M			$8.71	Q1 2022
12/31/2021	0.38%	0%	$28.1M	2.95M	-2,210	-0.07%	$9.51	Q4 2021
9/30/2021	0.73%		$49.7M	2.95M			$16.82	Q3 2021
6/30/2021	0.65%		$45.1M	2.95M			$15.27	Q2 2021
3/31/2021	0.94%		$57.6M	2.95M			$19.48	Q1 2021
12/31/2020	0.93%		$53.2M	2.95M			$18.02	Q4 2020
9/30/2020	1.27%		$57M	2.95M			$19.29	Q3 2020
6/30/2020	1.89%		$77.2M	2.95M			$26.12	Q2 2020
3/31/2020	1.44%		$52.7M	2.95M			$17.84	Q1 2020
12/31/2019	2.35%		$98.6M	2.95M			$33.37	Q4 2019
9/30/2019	1.71%		$70.4M	2.95M			$23.83	Q3 2019
6/30/2019	2.87%		$106M	2.95M			$35.94	Q2 2019
3/31/2019	2.93%	+0.45%	$109M	2.95M	+454,829	+18.2%	$36.94	Q1 2019
12/31/2018	3.11%		$108M	2.5M			$43.06	Q4 2018
9/30/2018	3.2%		$118M	2.5M			$47.23	Q3 2018
6/30/2018	3.53%	+0.64%	$124M	2.5M	+454,241	+22.2%	$49.76	Q2 2018
3/31/2018	3.22%	+0.84%	$102M	2.05M	+535,622	+35.5%	$49.69	Q1 2018
12/31/2017	2.17%	+1.35%	$56.2M	1.51M	+940,418	+165%	$37.21	Q4 2017
9/30/2017	0.73%	+0.56%	$18M	570K	+440,534	+341%	$31.52	Q3 2017
6/30/2017	0.11%	+0.11%	$2.33M	129K	+129,055	NEW	$18.06	Q2 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.